These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 29537325)

  • 1. A comparison of two different oral contraceptives in patients with severe primary dysmenorrhoea.
    Uysal G; Akkaya H; Cagli F; Tutus S; Tayyar AT
    J Obstet Gynaecol; 2018 Aug; 38(6):828-832. PubMed ID: 29537325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pelvic pain and quality of life of women with endometriosis during quadriphasic estradiol valerate/dienogest oral contraceptive: a patient-preference prospective 24-week pilot study.
    Grandi G; Xholli A; Napolitano A; Palma F; Cagnacci A
    Reprod Sci; 2015 May; 22(5):626-32. PubMed ID: 25394646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estradiol valerate plus dienogest versus ethinylestradiol plus levonorgestrel for the treatment of primary dysmenorrhea.
    Petraglia F; Parke S; Serrani M; Mellinger U; Römer T
    Int J Gynaecol Obstet; 2014 Jun; 125(3):270-4. PubMed ID: 24713413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the efficacy of Fructus agni casti in women with severe primary dysmenorrhea: a prospective comparative Doppler study.
    Aksoy AN; Gözükara I; Kabil Kucur S
    J Obstet Gynaecol Res; 2014 Mar; 40(3):779-84. PubMed ID: 24245554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of dienogest or combinations with ethinylestradiol/estradiol valerate on the pain score of women with endometriosis: A prospective cohort study.
    Yurtkal A; Oncul M
    Medicine (Baltimore); 2024 Jul; 103(27):e38585. PubMed ID: 38968535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative, open-label prospective study on the quality of life and sexual function of women affected by endometriosis-associated pelvic pain on 2 mg dienogest/30 µg ethinyl estradiol continuous or 21/7 regimen oral contraceptive.
    Caruso S; Iraci M; Cianci S; Fava V; Casella E; Cianci A
    J Endocrinol Invest; 2016 Aug; 39(8):923-31. PubMed ID: 27023105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose oral contraceptive pill for dysmenorrhea associated with endometriosis: a placebo-controlled, double-blind, randomized trial.
    Harada T; Momoeda M; Taketani Y; Hoshiai H; Terakawa N
    Fertil Steril; 2008 Nov; 90(5):1583-8. PubMed ID: 18164001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of heavy menstrual bleeding with the estradiol valerate and dienogest oral contraceptive pill.
    Micks EA; Jensen JT
    Adv Ther; 2013 Jan; 30(1):1-13. PubMed ID: 23239397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of low dose oral contraceptive pill containing drospirenone/ethinylestradiol in patients with endometrioma.
    Taniguchi F; Enatsu A; Ota I; Toda T; Arata K; Harada T
    Eur J Obstet Gynecol Reprod Biol; 2015 Aug; 191():116-20. PubMed ID: 26115056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of dienogest vs combined oral contraceptive on pain associated with endometriosis: Randomized clinical trial.
    El Taha L; Abu Musa A; Khalifeh D; Khalil A; Abbasi S; Nassif J
    Eur J Obstet Gynecol Reprod Biol; 2021 Dec; 267():205-212. PubMed ID: 34826668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormone withdrawal-associated symptoms: comparison of oestradiol valerate/dienogest versus ethinylestradiol/norgestimate.
    Jensen JT; Parke S; Mellinger U; Serrani M; Mabey RG
    Eur J Contracept Reprod Health Care; 2013 Aug; 18(4):274-83. PubMed ID: 23638631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gonadotrophin-releasing hormone analogue or dienogest plus estradiol valerate to prevent pain recurrence after laparoscopic surgery for endometriosis: a multi-center randomized trial.
    Granese R; Perino A; Calagna G; Saitta S; De Franciscis P; Colacurci N; Triolo O; Cucinella G
    Acta Obstet Gynecol Scand; 2015 Jun; 94(6):637-45. PubMed ID: 25761587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of low-dose combined drospirenone-ethinylestradiol on perimenstrual symptoms experienced by women with endometriosis.
    Tanaka Y; Mori T; Ito F; Koshiba A; Kusuki I; Kitawaki J
    Int J Gynaecol Obstet; 2016 Nov; 135(2):135-139. PubMed ID: 27477035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of a contraceptive pill containing estradiol valerate and dienogest (E2V/DNG) in women with menstrually-related migraine (MRM).
    Nappi RE; Terreno E; Sances G; Martini E; Tonani S; Santamaria V; Tassorelli C; Spinillo A
    Contraception; 2013 Sep; 88(3):369-75. PubMed ID: 23453784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estradiol valerate/dienogest: a novel oral contraceptive.
    Whalen KL; Rose R
    Ann Pharmacother; 2011 Oct; 45(10):1256-61. PubMed ID: 21917554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormonal contraception in women with endometriosis: a systematic review.
    Grandi G; Barra F; Ferrero S; Sileo FG; Bertucci E; Napolitano A; Facchinetti F
    Eur J Contracept Reprod Health Care; 2019 Feb; 24(1):61-70. PubMed ID: 30664383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of oral contraceptives containing estradiol and nomegestrol acetate or ethinyl-estradiol and chlormadinone acetate on primary dysmenorrhea.
    Grandi G; Napolitano A; Xholli A; Tirelli A; Di Carlo C; Cagnacci A
    Gynecol Endocrinol; 2015 Oct; 31(10):774-8. PubMed ID: 26291811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maintenance therapy with dienogest following gonadotropin-releasing hormone agonist treatment for endometriosis-associated pelvic pain.
    Kitawaki J; Kusuki I; Yamanaka K; Suganuma I
    Eur J Obstet Gynecol Reprod Biol; 2011 Aug; 157(2):212-6. PubMed ID: 21474232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ethinylestradiol 20 μg/drospirenone 3 mg in a flexible extended regimen for the management of endometriosis-associated pelvic pain: a randomized controlled trial.
    Harada T; Kosaka S; Elliesen J; Yasuda M; Ito M; Momoeda M
    Fertil Steril; 2017 Nov; 108(5):798-805. PubMed ID: 28911925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous Norethisterone Acetate versus Cyclical Drospirenone 3 mg/Ethinyl Estradiol 20 μg for the Management of Primary Dysmenorrhea in Young Adult Women.
    Al-Jefout M; Nawaiseh N
    J Pediatr Adolesc Gynecol; 2016 Apr; 29(2):143-7. PubMed ID: 26342733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.